NASDAQ: XERSXeris Biopharma Holdings Inc Stock Ownership - Who owns Xeris Biopharma Holdings?
Insider buying vs selling
Have Xeris Biopharma Holdings Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| John Johnson | Director | 2024-03-18 | 215,600 | $1.99 | $429.04kBuy |
| John P. Schmid | Director | 2024-03-14 | 4,500 | $2.16 | $9.72kBuy |
| Jeffrey W. Sherman | Director | 2023-11-27 | 5,400 | $1.87 | $10.10kBuy |
| Steven Pieper | Chief Financial Officer | 2023-11-20 | 28,000 | $1.95 | $54.60kBuy |
| Dawn Halkuff | Director | 2023-11-20 | 5,410 | $1.84 | $9.95kBuy |
| John Patrick Shannon Jr. | President and Chief Operating Officer | 2023-11-17 | 30,769 | $1.64 | $50.40kBuy |
| John P. Schmid | Director | 2023-11-16 | 6,500 | $1.51 | $9.82kBuy |
| Marla Persky | Director | 2023-11-14 | 6,370 | $1.58 | $10.06kBuy |
| Paul R. Edick | Chairman and Chief Executive Officer | 2023-08-09 | 10,000 | $2.38 | $23.79kBuy |
XERS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when XERS insiders and whales buy or sell their stock.
XERS Shareholders
What type of owners hold Xeris Biopharma Holdings Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 7.13% | 10,011,391 | $17.62M | Institution |
| Vanguard Group Inc | 5.05% | 7,086,345 | $12.47M | Institution |
| Stonepine Capital Management LLC | 4.23% | 5,937,000 | $10.45M | Institution |
| Caxton Corp | 4.02% | 5,641,920 | $9.93M | Institution |
| Redmile Group LLC | 3.85% | 5,413,284 | $9.53M | Insider |
| Paul R. Edick | 2.75% | 3,868,354 | $6.81M | Insider |
| Mpm Bioimpact LLC | 2.74% | 3,847,232 | $6.77M | Institution |
| Rosalind Advisors Inc | 2.52% | 3,543,685 | $6.24M | Institution |
| Geode Capital Management LLC | 2.06% | 2,892,077 | $5.09M | Institution |
| State Street Corp | 1.94% | 2,724,126 | $4.79M | Institution |
XERS vs Biotech Stocks
Xeris Biopharma Holdings Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.